European Public Assessment Report summary screen versions: original (round 3) and revised (round 4)
| Original (round 3) | Revised (round 4) | ||||
|---|---|---|---|---|---|
| Questions | Number of points found /understood | Target met? | Number found/understood | Target met? | |
| 1 | Who has this report been written for? | 4 / 0 | No | 10 / 9 | Yes |
| 2 | When is Bondronat used in breast cancer? | 9 / 1 | No | 10 / 9 | Yes |
| 3 | What is the purpose of this report? | 6 / 0 | No | 9 / 9 | Yes |
| 4 | What can the tablets do to the food pipe? | 10 / 0 | No | 10 / 10 | Yes |
| 5 | Who made the decision about Bondronat described in this report? | 9 / 0 | No | 10 / 9 | Yes |
| 6 | What group of medicines does Bondronat belong to? | 5 / 5 | No | 10 / 10 | Yes |
| 7 | What did the Committee for Medicinal Products for Human Use (CHMP) decide about Bondronat? | 9 / 8 | Yes | 10 / 9 | Yes |
| 8 | The tablets can irritate the food pipe. Which people cannot have the tablets as a result of this? | 10 / 9 | Yes | 9 / 8 | Yes |
| 9 | What two things were weighed up before the decision was made about whether Bondronat should be approved? | 3 / 3 | No | 10 / 10 | Yes |
| 10 | How does Bondronat prevent fractures, or broken bones? | 10 / 9 | Yes | 7 / 6 | No |
| 11 | In the studies looking into bone problems or complications, what was looked at to see if Bondronat was working? | 8 / 8 | No | 7 / 7 | No |
| 12 | During the studies into high calcium levels, how many people did the 4 mg dose work in? | 7 / 7 | No | 10 / 9 | Yes |
| 13 | How many people receiving a Bondronat infusion got a fever? | 10 / 9 | Yes | 10 / 9 | Yes |
| 14 | During the study of bone complications, what was Bondronat compared with? | 10 / 8 | No | 10 / 10 | Yes |
| 15 | Suppose you want more information on how the decision was made about Bondronat, what should you do? | 7 / 2 | No | 10 / 9 | Yes |
| 16 | How many people taking the Bondronat tablet got an inflamed food pipe? | 9 / 8 | Yes | 10 / 10 | Yes |
| 17 | In the research studies of high calcium levels in the blood, what was Bondronat compared against? | 7 / 7 | No | 9 / 9 | Yes |
| 18 | When Bondronat was studied in the treatment of bone complications, which group of patients got a new bone problem first? | 6 / 5 | No | 8 / 5 | No |
| 19 | If you are a patient and want more information about Bondronat, what should you do? | 9 / 9 | Yes | 10 / 10 | Yes |
| Total number of passes | 6 | 16 | |||